Cannara Biotech Inc. Share Price Canadian Securities Exchange
Equities
LOVE
CA13765U1012
Healthcare Facilities & Services
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- CAD | -.--% | -.--% | +87.50% |
01-29 | Cannara Biotech Inc. Reports Earnings Results for the First Quarter Ended November 30, 2023 | CI |
2023 | Cannara Biotech Inc. Reports Earnings Results for the Full Year Ended August 31, 2023 | CI |
Sales 2022 | 35.84M 26.2M 2.1B | Sales 2023 | 57.26M 41.86M 3.35B | Capitalization | 90.41M 66.09M 5.29B |
---|---|---|---|---|---|
Net income 2022 | 2M 1.46M 117M | Net income 2023 | 6M 4.39M 351M | EV / Sales 2022 | 4.32 x |
Net Debt 2022 | 36.28M 26.52M 2.12B | Net Debt 2023 | 41.51M 30.35M 2.43B | EV / Sales 2023 | 2.3 x |
P/E ratio 2022 |
135
x | P/E ratio 2023 |
12.9
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 50.58% |
Managers | Title | Age | Since |
---|---|---|---|
Zohar Krivorot
CEO | Chief Executive Officer | 48 | 30/12/18 |
Nicholas Sosiak
DFI | Director of Finance/CFO | - | 31/03/19 |
Avi Krivorot
CTO | Chief Tech/Sci/R&D Officer | - | 31/03/21 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jacob M. Kay
BRD | Director/Board Member | 83 | 24/05/19 |
Donald Olds
BRD | Director/Board Member | 64 | 09/11/20 |
Zohar Krivorot
CEO | Chief Executive Officer | 48 | 30/12/18 |
1st Jan change | Capi. | |
---|---|---|
+31.96% | 272M | |
+33.74% | 261M | |
+49.42% | 194M | |
+44.98% | 131M | |
-42.17% | 119M | |
-28.57% | 121M | |
+115.91% | 119M | |
0.00% | 86.82M | |
+150.00% | 75.33M |
- Stock Market
- Equities
- LOVE Stock
- LOVE Stock